Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Zolpidem tartrate
Medication labelZolpidem tartrate extended-release tablets is indicated for the short-term treatment of insomnia characterized by difficulties with sleep…
Why this: Advisory · dailymed-prescription
Zolpidem tartrate extended-release tablets is indicated for the short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset). The clinical trials performed in support of efficacy were up to 3 weeks (using polysomnography measurement up to 2 weeks in both adult and elderly patients) and 24 weeks (using patient reported assessment in adult patients only) in duration [see Clinical Studies (14)].
- generic_name
- zolpidem tartrate
- product_names
- zolpidem tartrate
- ndc
- 51407-761, 51407-762, 0713-5521, 51407-762-01, 0713-5501, 51407-761-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en